Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: A survey of gynecologic oncology committee of Japan society of obstetrics and gynecology

Mikio Mikami, Satoru Nagase, Wataru Yamagami, Kimio Ushijma, Hironori Tashiro, Hidetaka Katabuchi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: Recent evidence has supported the concept that epithelial ovarian cancer (EOC) arises from the cells of the fallopian tube or endometrium. This study investigated current practice in Japan with respect to performing opportunistic bilateral salpingectomy (OBS) during gynecological surgery for benign disease for Ovarian Cancer Prevention. Methods: We mailed a questionnaire to 767 hospitals and clinics, comprising 628 accredited training institutions of the Japan Society of Obstetrics and Gynecology (JSOG), Japan Society of Gynecologic Oncology (JSGO), or Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy (JSGOE) and 139 private institutions with at least one JSGOE-certified licensed gynecologic laparoscopist. Results: Among the 767 institutions, 444 (57.9%) provided responses, including 91 (20.6%) that were both JSGOE and JSGO accredited, 71 (16.0%) that were only JSGO accredited, 88 (19.8%) that were only JSGOE accredited, and 194 (43.7%) that were unaccredited. It was found that awareness and performance of OBS largely depended on the JSGO and/or JSGOE accreditation status. OBS was only performed at 54.0% of responding institutions and just 6.8% of the institutions were willing to participate in randomized controlled trials to validate this method for reducing the incidence of ovarian cancer. Conclusion: The JSOG Gynecologic Tumor Committee will announce its opinion on salpingectomy for ovarian cancer prevention to all JSOG members and will develop a system for monitoring the number of OBS procedures in Japan.

Original languageEnglish
Article numbere52
JournalJournal of Gynecologic Oncology
Volume28
Issue number4
DOIs
Publication statusPublished - 2017

Fingerprint

Salpingectomy
Gynecologic Surgical Procedures
Gynecology
Ovarian Neoplasms
Obstetrics
Japan
Surveys and Questionnaires
Fallopian Tubes
Accreditation
Endometrium
Endoscopy
Randomized Controlled Trials

Keywords

  • Ovarian Neoplasms
  • Prevention & Control
  • Salpingectomy

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention : A survey of gynecologic oncology committee of Japan society of obstetrics and gynecology. / Mikami, Mikio; Nagase, Satoru; Yamagami, Wataru; Ushijma, Kimio; Tashiro, Hironori; Katabuchi, Hidetaka.

In: Journal of Gynecologic Oncology, Vol. 28, No. 4, e52, 2017.

Research output: Contribution to journalArticle

@article{b53505fc0abd4f02aa2df2e788a23c10,
title = "Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: A survey of gynecologic oncology committee of Japan society of obstetrics and gynecology",
abstract = "Objective: Recent evidence has supported the concept that epithelial ovarian cancer (EOC) arises from the cells of the fallopian tube or endometrium. This study investigated current practice in Japan with respect to performing opportunistic bilateral salpingectomy (OBS) during gynecological surgery for benign disease for Ovarian Cancer Prevention. Methods: We mailed a questionnaire to 767 hospitals and clinics, comprising 628 accredited training institutions of the Japan Society of Obstetrics and Gynecology (JSOG), Japan Society of Gynecologic Oncology (JSGO), or Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy (JSGOE) and 139 private institutions with at least one JSGOE-certified licensed gynecologic laparoscopist. Results: Among the 767 institutions, 444 (57.9{\%}) provided responses, including 91 (20.6{\%}) that were both JSGOE and JSGO accredited, 71 (16.0{\%}) that were only JSGO accredited, 88 (19.8{\%}) that were only JSGOE accredited, and 194 (43.7{\%}) that were unaccredited. It was found that awareness and performance of OBS largely depended on the JSGO and/or JSGOE accreditation status. OBS was only performed at 54.0{\%} of responding institutions and just 6.8{\%} of the institutions were willing to participate in randomized controlled trials to validate this method for reducing the incidence of ovarian cancer. Conclusion: The JSOG Gynecologic Tumor Committee will announce its opinion on salpingectomy for ovarian cancer prevention to all JSOG members and will develop a system for monitoring the number of OBS procedures in Japan.",
keywords = "Ovarian Neoplasms, Prevention & Control, Salpingectomy",
author = "Mikio Mikami and Satoru Nagase and Wataru Yamagami and Kimio Ushijma and Hironori Tashiro and Hidetaka Katabuchi",
year = "2017",
doi = "10.3802/jgo.2017.28.e52",
language = "English",
volume = "28",
journal = "Journal of Gynecologic Oncology",
issn = "2005-0380",
publisher = "Korean Society of Gynecologic Oncology and Colposcopy",
number = "4",

}

TY - JOUR

T1 - Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention

T2 - A survey of gynecologic oncology committee of Japan society of obstetrics and gynecology

AU - Mikami, Mikio

AU - Nagase, Satoru

AU - Yamagami, Wataru

AU - Ushijma, Kimio

AU - Tashiro, Hironori

AU - Katabuchi, Hidetaka

PY - 2017

Y1 - 2017

N2 - Objective: Recent evidence has supported the concept that epithelial ovarian cancer (EOC) arises from the cells of the fallopian tube or endometrium. This study investigated current practice in Japan with respect to performing opportunistic bilateral salpingectomy (OBS) during gynecological surgery for benign disease for Ovarian Cancer Prevention. Methods: We mailed a questionnaire to 767 hospitals and clinics, comprising 628 accredited training institutions of the Japan Society of Obstetrics and Gynecology (JSOG), Japan Society of Gynecologic Oncology (JSGO), or Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy (JSGOE) and 139 private institutions with at least one JSGOE-certified licensed gynecologic laparoscopist. Results: Among the 767 institutions, 444 (57.9%) provided responses, including 91 (20.6%) that were both JSGOE and JSGO accredited, 71 (16.0%) that were only JSGO accredited, 88 (19.8%) that were only JSGOE accredited, and 194 (43.7%) that were unaccredited. It was found that awareness and performance of OBS largely depended on the JSGO and/or JSGOE accreditation status. OBS was only performed at 54.0% of responding institutions and just 6.8% of the institutions were willing to participate in randomized controlled trials to validate this method for reducing the incidence of ovarian cancer. Conclusion: The JSOG Gynecologic Tumor Committee will announce its opinion on salpingectomy for ovarian cancer prevention to all JSOG members and will develop a system for monitoring the number of OBS procedures in Japan.

AB - Objective: Recent evidence has supported the concept that epithelial ovarian cancer (EOC) arises from the cells of the fallopian tube or endometrium. This study investigated current practice in Japan with respect to performing opportunistic bilateral salpingectomy (OBS) during gynecological surgery for benign disease for Ovarian Cancer Prevention. Methods: We mailed a questionnaire to 767 hospitals and clinics, comprising 628 accredited training institutions of the Japan Society of Obstetrics and Gynecology (JSOG), Japan Society of Gynecologic Oncology (JSGO), or Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy (JSGOE) and 139 private institutions with at least one JSGOE-certified licensed gynecologic laparoscopist. Results: Among the 767 institutions, 444 (57.9%) provided responses, including 91 (20.6%) that were both JSGOE and JSGO accredited, 71 (16.0%) that were only JSGO accredited, 88 (19.8%) that were only JSGOE accredited, and 194 (43.7%) that were unaccredited. It was found that awareness and performance of OBS largely depended on the JSGO and/or JSGOE accreditation status. OBS was only performed at 54.0% of responding institutions and just 6.8% of the institutions were willing to participate in randomized controlled trials to validate this method for reducing the incidence of ovarian cancer. Conclusion: The JSOG Gynecologic Tumor Committee will announce its opinion on salpingectomy for ovarian cancer prevention to all JSOG members and will develop a system for monitoring the number of OBS procedures in Japan.

KW - Ovarian Neoplasms

KW - Prevention & Control

KW - Salpingectomy

UR - http://www.scopus.com/inward/record.url?scp=85020623740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020623740&partnerID=8YFLogxK

U2 - 10.3802/jgo.2017.28.e52

DO - 10.3802/jgo.2017.28.e52

M3 - Article

C2 - 28541639

AN - SCOPUS:85020623740

VL - 28

JO - Journal of Gynecologic Oncology

JF - Journal of Gynecologic Oncology

SN - 2005-0380

IS - 4

M1 - e52

ER -